Importantly, JAK2 directly phosphorylates BECN1 at Y333, leading to an enhanced BECN1-VPS34 interaction and autophagy, a mechanism by which IL-6 regulates cancer chemotherapy resistance. The gene discussed is BECN1; the disease is cancer.